ReviewThe oncologist2019

Comprehensive Clinical Trial Data Summation for BRAF-MEK Inhibition and Checkpoint Immunotherapy in Metastatic Melanoma.

Jason J LukePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.